Stay updated on Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel
Sign up to get notified when there's something new on the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page.

Latest updates to the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page
- Check7 days agoChange DetectedLocations updated to Temuco (Araucania) and Viña del Mar (Valparaiso) with new site IDs. Regional references were removed and revision upgraded from v3.5.0 to v3.5.2.SummaryDifference0.3%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision: v3.4.3 was deployed, replacing v3.4.2. This appears to be a minor maintenance update with no visible changes to the study details on the page.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.4.2 is now shown in the page footer, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange DetectedFooter Revision label updated from v3.4.0 to v3.4.1. This is a minor maintenance update with no impact on study details or site navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check92 days agoChange DetectedAdded a glossary toggle and updated QC metadata to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous capitalization and version text.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel
Enter your email address, and we'll notify you when there's something new on the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page.